- Home
- DHY vs SOPH Comparison
DHY vs SOPH Comparison
Compare DHY & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- SOPH
- Stock Information
- Founded
- DHY 1998
- SOPH 2011
- Country
- DHY United States
- SOPH Switzerland
- Employees
- DHY N/A
- SOPH N/A
- Industry
- DHY Finance/Investors Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DHY Finance
- SOPH Health Care
- Exchange
- DHY Nasdaq
- SOPH Nasdaq
- Market Cap
- DHY 216.5M
- SOPH 231.8M
- IPO Year
- DHY N/A
- SOPH 2021
- Fundamental
- Price
- DHY $2.06
- SOPH $4.68
- Analyst Decision
- DHY
- SOPH
- Analyst Count
- DHY 0
- SOPH 0
- Target Price
- DHY N/A
- SOPH N/A
- AVG Volume (30 Days)
- DHY 569.1K
- SOPH 143.2K
- Earning Date
- DHY 01-01-0001
- SOPH 11-04-2025
- Dividend Yield
- DHY 9.10%
- SOPH N/A
- EPS Growth
- DHY N/A
- SOPH N/A
- EPS
- DHY N/A
- SOPH N/A
- Revenue
- DHY N/A
- SOPH $73,297,000.00
- Revenue This Year
- DHY N/A
- SOPH $16.60
- Revenue Next Year
- DHY N/A
- SOPH $19.09
- P/E Ratio
- DHY N/A
- SOPH N/A
- Revenue Growth
- DHY N/A
- SOPH 13.66
- 52 Week Low
- DHY $1.77
- SOPH $2.58
- 52 Week High
- DHY $2.08
- SOPH $5.30
- Technical
- Relative Strength Index (RSI)
- DHY 44.60
- SOPH 56.53
- Support Level
- DHY $2.05
- SOPH $4.01
- Resistance Level
- DHY $2.09
- SOPH $5.30
- Average True Range (ATR)
- DHY 0.02
- SOPH 0.40
- MACD
- DHY 0.00
- SOPH 0.04
- Stochastic Oscillator
- DHY 50.00
- SOPH 60.00
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.